Drug intelligence / Profile preview

NW-BR CEPA PLUS

Development stage: Unknown
Lead developer: FARVET
Modality: Vaccines & Immunotherapeutics
Administration: Ophthalmic, Oral, Spray

Overview

NW-BR CEPA PLUS is a live attenuated combination vaccine developed by FARVET for the prevention of Newcastle Disease and Infectious Bronchitis in poultry. The vaccine contains the LaSota strain of Newcastle Disease Virus (NDV) and the Massachusetts strain of Infectious Bronchitis Virus (IBV) in a lyophilized (freeze-dried) format. Upon administration, the attenuated viruses replicate in the host, stimulating a robust humoral and cellular immune response without causing severe disease. This dual-action vaccine provides broad protection against two of the most economically significant viral respiratory pathogens in the poultry industry. It is typically administered via ophthalmic, oral (drinking water), or spray routes to ensure effective coverage across a flock.

Brand names: NW-BR CEPA PLUS
Other names: NW-BR CEPA PLUS-FARVET

Beyond the preview

Go deeper on NW-BR CEPA PLUS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NW-BR CEPA PLUS.

Explore the full profile